Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic plc Announces Hugo Robotic-Assisted Surgery System Cornerstone of New Robotics Program in Latin America

07/20/2021 | 09:50am EDT

Medtronic plc announced the integration of the Hugo robotic-assisted surgery (RAS) system at Hospital Clinico de la Red de Salud UC CHRISTUS in Santiago, Chile, to support the teaching institution's new robotic surgery program. UC CHRISTUS is the latest institution to join Medtronic's Partners in Possibility Program, a group of pioneering hospitals that will be among the first in the world to use the Hugo RAS system in support of the Hugo system patient registry. In Latin America, approximately 75% of surgeries are conducted as open procedures.1 With minimally invasive surgery, those patients could experience fewer complications, shorter hospital stays, faster return to normal activities, and smaller scars. Robotic surgery is a form of minimally invasive surgery that offers surgeons improved visualization, greater dexterity, and ergonomic advantages, yet robots are used in less than 3% of surgeries globally.1 The Hugo RAS system — Medtronic's solution to historic cost and utilization barriers that have kept surgical robotics out of reach for many hospitals — is a modular, multi-quadrant platform designed for a broad range of soft-tissue procedures. The Hugo RAS system combines the precision of wristed instruments with the flexibility of independent robotic arm carts and best-in-class 3D visualization technology on an open console. Touch Surgery™ Enterprise, a cloud-based surgical video capture option powered by artificial intelligence, allows surgeons to seamlessly record, analyze, and share Hugo system case footage. In support of its commitment to expand access to quality care, Medtronic has opened a new Surgical Robotics Experience Center in Santiago. This is the company's first in Latin America and 1 of 10 world-class facilities around the globe where clinicians can experience and train on the Hugo RAS system. The Santiago Surgical Robotics Experience Center operates in partnership with the Faculty of Medicine of Pontificia Universidad Católica de Chile, which is affiliated with UC CHRISTUS.


ę S&P Capital IQ 2021
All news about MEDTRONIC PLC
09/27MEDTRONIC : Says First Procedure Using Its Robotic-Assisted Surgery System Performed in In..
MT
09/27MEDTRONIC : First Procedure in Asia-Pacific Performed with Medtronic Hugo™ Robotic-A..
AQ
09/24IAC/INTERACTIVECORP : IAC in Talks to Acquire Meredith in Potential $2.5 Billion Deal
MT
09/23AXONICS : Confident It Doesn't Infringe Any Medtronic Patent Despite US Patent Office Pane..
MT
09/23MEDTRONIC : Wins US Patent Office's Affirmation On Three Bladder Device Patents
MT
09/23MEDTRONIC PLC : Ex-dividend day for
FA
09/22MEDTRONIC : Enrolls First Patient in Pediatric Trial for Treatment of Scoliosis
MT
09/22MEDTRONIC : U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics..
PR
09/22MEDTRONIC : Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis
AQ
09/22Medtronic plc Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scolios..
CI
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 991 M - -
Net income 2022 5 704 M - -
Net Debt 2022 20 694 M - -
P/E ratio 2022 32,4x
Yield 2022 1,87%
Capitalization 173 B 173 B -
EV / Sales 2022 5,88x
EV / Sales 2023 5,52x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 128,75 $
Average target price 145,92 $
Spread / Average Target 13,3%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC9.91%173 273
ABBOTT LABORATORIES10.13%220 485
BECTON, DICKINSON AND COMPANY0.48%72 711
HOYA CORPORATION29.36%62 143
ALIGN TECHNOLOGY, INC.31.19%57 302
SARTORIUS STEDIM BIOTECH77.82%55 891